Induct AS (OSL:INDCT)
3.380
-0.100 (-2.87%)
At close: Sep 12, 2025
Induct AS Revenue
Induct AS had revenue of 4.28M NOK in the quarter ending June 30, 2025, a decrease of -3.78%. This brings the company's revenue in the last twelve months to 17.32M, down -12.80% year-over-year. In the year 2024, Induct AS had annual revenue of 17.96M, down -14.62%.
Revenue (ttm)
17.32M
Revenue Growth
-12.80%
P/S Ratio
6.11
Revenue / Employee
1.33M
Employees
13
Market Cap
105.82M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2024 | 17.96M | -3.08M | -14.62% |
Dec 31, 2023 | 21.04M | 1.60M | 8.25% |
Dec 31, 2022 | 19.44M | 5.13M | 35.85% |
Dec 31, 2021 | 14.31M | 2.70M | 23.32% |
Dec 31, 2020 | 11.60M | -2.18M | -15.84% |
Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Dec 31, 2015 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Medistim ASA | 628.08M |
Nordhealth AS | 578.17M |
Photocure ASA | 522.86M |
ArcticZymes Technologies ASA | 104.33M |
Vistin Pharma ASA | 452.25M |
Omda AS | 458.96M |
Gentian Diagnostics ASA | 163.38M |
Lytix Biopharma AS | 608.00K |